Morrissey PE |
Prope tolerance: is it the end or the means? |
2009 |
Transplantation |
pmid:19502973
|
Alloway RR |
Mounting Clinical Evidence With Tacrolimus Generic Products. |
2017 |
Transplantation |
pmid:28749820
|
Prókai à et al. |
Calcineurin-inhibition Results in Upregulation of Local Renin and Subsequent Vascular Endothelial Growth Factor Production in Renal Collecting Ducts. |
2016 |
Transplantation |
pmid:26502369
|
Egawa H et al. |
FK506 conversion therapy in pediatric liver transplantation. |
1994 |
Transplantation |
pmid:7513911
|
Yang CW et al. |
Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney. |
2001 |
Transplantation |
pmid:11740384
|
McGhee B et al. |
Therapeutic use of an extemporaneously prepared oral suspension of tacrolimus in pediatric patients. |
1997 |
Transplantation |
pmid:9326429
|
Yoshimura N et al. |
The direct effect of FK506 and rapamycin on interleukin 1(beta) and immunoglobulin production in vitro. |
1994 |
Transplantation |
pmid:7517078
|
Firdaous I et al. |
Pediatric intravenous FK506--how much are we really infusing? |
1994 |
Transplantation |
pmid:7517079
|
Soccal PM et al. |
Improvement of drug-induced chronic renal failure in lung transplantation. |
1999 |
Transplantation |
pmid:10428288
|
Muthukumar T et al. |
HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles. |
2013 |
Transplantation |
pmid:23503504
|
Lee CM et al. |
Outcomes in diabetic patients after simultaneous pancreas-kidney versus kidney alone transplantation. |
1997 |
Transplantation |
pmid:9371670
|
Dhar DK et al. |
Effective prevention of ischemic injury of the dearterialized canine liver by FK506 pretreatment. |
1993 |
Transplantation |
pmid:7506456
|
Hricik DE et al. |
Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus. |
2007 |
Transplantation |
pmid:17297401
|
Burke MD et al. |
Inhibition of the metabolism of cyclosporine by human liver microsomes by FK506. |
1990 |
Transplantation |
pmid:1700507
|
Sharif A et al. |
Insulin resistance indexes in renal transplant recipients maintained on tacrolimus immunosuppression. |
2010 |
Transplantation |
pmid:20145524
|
Abu-Qaoud MS et al. |
Lack of relationship between microvascular and macrovascular disease in heart transplant recipients. |
2012 |
Transplantation |
pmid:23044666
|
Kaplan B et al. |
Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: possible relationship to intestinal P-glycoprotein activity. |
1999 |
Transplantation |
pmid:10075604
|
Woodward RS et al. |
Renal graft survival and calcineurin inhibitor. |
2005 |
Transplantation |
pmid:16177637
|
Moutabarrik A et al. |
FK506-induced kidney tubular cell injury. |
1992 |
Transplantation |
pmid:1281562
|
Ciancio G et al. |
The use of Campath-1H as induction therapy in renal transplantation: preliminary results. |
2004 |
Transplantation |
pmid:15316372
|
Uemura T et al. |
Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation. |
2011 |
Transplantation |
pmid:21841541
|
Aw MM et al. |
Calcineurin-inhibitor related nephrotoxicity- reversibility in paediatric liver transplant recipients. |
2001 |
Transplantation |
pmid:11544444
|
Terakura M et al. |
Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow. |
1998 |
Transplantation |
pmid:9721804
|
Kai N et al. |
Prevention of insulitis and diabetes in nonobese diabetic mice by administration of FK506. |
1993 |
Transplantation |
pmid:7682740
|
Jacobson PA et al. |
Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium. |
2011 |
Transplantation |
pmid:21206424
|
Nolan TJ and Schad GA |
Tacrolimus allows autoinfective development of the parasitic nematode Strongyloides stercoralis. |
1996 |
Transplantation |
pmid:8878405
|
Opelz G and Döhler B |
Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation. |
2009 |
Transplantation |
pmid:19300179
|
Rostambeigi N et al. |
Unique cellular and mitochondrial defects mediate FK506-induced islet β-cell dysfunction. |
2011 |
Transplantation |
pmid:21200364
|
Mikhalski D et al. |
Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. |
2008 |
Transplantation |
pmid:18401260
|
Jordan ML et al. |
Tacrolimus rescue therapy for renal allograft rejection--five-year experience. |
1997 |
Transplantation |
pmid:9020321
|
Dhar DK et al. |
The salutary effect of FK506 in ischemia-reperfusion injury of the canine liver. |
1992 |
Transplantation |
pmid:1384188
|
Bashuda H et al. |
Induction of persistent allograft tolerance in the rat by combined treatment with anti-leukocyte function-associated antigen-1 and anti-intercellular adhesion molecule-1 monoclonal antibodies, donor-specific transfusion, and FK506. |
1996 |
Transplantation |
pmid:8693525
|
Ericzon BG et al. |
FK506-induced impairment of glucose metabolism in the primate--studies in pancreatic transplant recipients and in nontransplanted animals. |
1992 |
Transplantation |
pmid:1384189
|
Ciancio G et al. |
A randomized pilot study of donor stem cell infusion in living-related kidney transplant recipients receiving alemtuzumab. |
2013 |
Transplantation |
pmid:23903014
|
Nakazawa Y et al. |
Relationship between in vivo FK506 clearance and in vitro 13-demethylation activity in living-related liver transplantation. |
1998 |
Transplantation |
pmid:9808496
|
Lerut J et al. |
Anti-CD2 monoclonal antibody and tacrolimus in adult liver transplantation. |
2005 |
Transplantation |
pmid:16314784
|
Gruessner RW et al. |
Over 500 solitary pancreas transplants in nonuremic patients with brittle diabetes mellitus. |
2008 |
Transplantation |
pmid:18192910
|
Komori K et al. |
The role of graft and host accommodation in a hamster-to-rat cardiac transplantation model. |
2008 |
Transplantation |
pmid:18192920
|
Meiser BM et al. |
Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients? |
2004 |
Transplantation |
pmid:15446320
|
Jordan ML et al. |
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. |
1994 |
Transplantation |
pmid:7512293
|
Kashu Y et al. |
The effect of combination splenectomy and low-dose FK506 therapy on graft survival after liver allograft transplantation in rats. |
1996 |
Transplantation |
pmid:8633382
|
Lauzurica R et al. |
Subclinical inflammation in renal transplant recipients: impact of cyclosporine microemulsion versus tacrolimus. |
2007 |
Transplant. Proc. |
pmid:17889127
|
Miura S et al. |
Long-term results of spousal renal donor transplants with donor-specific blood transfusions. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750463
|
Sato S et al. |
Specificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636517
|
Pérez-Flores I et al. |
Intracellular ATP levels in CD4+ lymphocytes are a risk marker of rejection and infection in renal graft recipients. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715845
|
Spinelli GA et al. |
Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen. |
2011 |
Transplant. Proc. |
pmid:22172836
|
Mac Guad R et al. |
Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients. |
|
Transplant. Proc. |
pmid:26915847
|
Tsugita M et al. |
Hepatocytes or liver nonparenchymal cells plus FK 506 prolong liver xenograft survival. |
1994 |
Transplant. Proc. |
pmid:7527969
|
Okamoto M et al. |
Beneficial effect of multiple drug therapy including tacrolimus in clinical renal transplantation. |
2000 |
Transplant. Proc. |
pmid:11119905
|
Kuroki H et al. |
Effect of FK 506 and donor-specific blood transfusion on the rat composite tissue limb allograft and the mechanism of long-term graft survival. |
1993 |
Transplant. Proc. |
pmid:7679833
|
Machida M et al. |
Effect of temperature and hematocrit on plasma concentration of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721266
|
Ko S et al. |
Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation. |
1996 |
Transplant. Proc. |
pmid:8623229
|
Zeevi A et al. |
Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression. |
1990 |
Transplant. Proc. |
pmid:1689902
|
Ruiz MC et al. |
Effect of early versus delayed calcineurin inhibitor treatment on delayed graft function. |
2003 |
Transplant. Proc. |
pmid:12644096
|
Roman A et al. |
Preliminary results of rescue therapy with tacrolimus and mycophenolate mofetil in lung transplanted patients with bronchiolitis obliterans. |
2002 |
Transplant. Proc. |
pmid:11959227
|
Ueno T et al. |
Renal dysfunction following adult intestinal transplant under tacrolimus-based immunosuppression. |
2006 Jul-Aug |
Transplant. Proc. |
pmid:16908274
|
Abe M et al. |
Successful prednisone withdrawal after living-related liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636584
|
Bora F et al. |
Drug interaction between tacrolimus and ertapenem in renal transplantation recipients. |
2012 |
Transplant. Proc. |
pmid:23195020
|
Crespo-Leiro MG |
Calcineurin inhibitors in heart transplantation. |
2005 |
Transplant. Proc. |
pmid:16386614
|
Braun F et al. |
Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk". |
2000 |
Transplant. Proc. |
pmid:11120281
|
Woodle ES et al. |
Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience. |
1999 |
Transplant. Proc. |
pmid:10576053
|
Florman S et al. |
Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen. |
2005 |
Transplant. Proc. |
pmid:15848672
|
Alessiani M et al. |
Total orthotopic small bowel transplantation in swine under FK 506. |
1994 |
Transplant. Proc. |
pmid:7518148
|
Date K et al. |
Effect of FK 506 on graft survival in rat small intestinal allografts. |
1992 |
Transplant. Proc. |
pmid:1376516
|
Murase N et al. |
Bone marrow augmentation for heart, liver, and small bowel transplantation: prolongation of graft survival and incidence of graft-versus-host disease. |
1995 |
Transplant. Proc. |
pmid:7533386
|
Ishibashi M et al. |
Effect of FK 506 on generation of activated macrophages invading rejected skin allografts in rats: discrepancy of in vitro versus in vivo effects. |
1991 |
Transplant. Proc. |
pmid:1721330
|
Mortensen DM et al. |
Calcineurin activity in tacrolimus-treated renal transplant patients early after and 5 years after transplantation. |
2006 |
Transplant. Proc. |
pmid:17098028
|
Loucaidou M et al. |
Late steroid withdrawal for renal transplant recipients on tacrolimus and MMF is safe. |
2005 |
Transplant. Proc. |
pmid:15919469
|
Malyszko J et al. |
A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients. |
2009 |
Transplant. Proc. |
pmid:19857675
|
Scantlebury VP et al. |
Outcome of kidney transplantation in African-Americans using tacrolimus. |
1997 |
Transplant. Proc. |
pmid:9414906
|
Yagihashi A et al. |
HLA matching effect in liver transplantation. |
1992 |
Transplant. Proc. |
pmid:1281569
|
McCauley J et al. |
Renal transplantation under FK 506 in patients with previous loss of renal function due to hemolytic uremic syndrome. |
1991 |
Transplant. Proc. |
pmid:1721362
|
Zeevi A et al. |
Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection. |
1991 |
Transplant. Proc. |
pmid:1703341
|
Sánchez-Fructuoso AI et al. |
Daclizumab induction as an immunosuppressive regimen for renal transplant recipients from non-heart-beating donors. |
2003 |
Transplant. Proc. |
pmid:12962759
|
Miyazawa H et al. |
Graft immunomodulation by donor irradiation and recipient-specific bone marrow cells in rat small bowel transplantation. |
2002 |
Transplant. Proc. |
pmid:12072357
|
Coupes BM et al. |
Tacrolimus monotherapy in renal transplantation: four-year data. |
2002 |
Transplant. Proc. |
pmid:12176506
|
Jeong HJ et al. |
Vascular endothelin, TGF-beta, and PDGF expression in FK506 nephrotoxicity of rats. |
1998 |
Transplant. Proc. |
pmid:9838576
|
Lohmann R et al. |
Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083151
|
Misao T et al. |
Effect of donor splenocyte transfusion with a simultaneous single injection of tacrolimus on lung allografts. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123153
|
Kim JD et al. |
Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis. |
2016 |
Transplant. Proc. |
pmid:27320573
|
Hesse CJ et al. |
The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation. |
2001 |
Transplant. Proc. |
pmid:11377487
|
Uchida K et al. |
Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176556
|
Wu MS et al. |
Cyclosporine, but not FK506 and rapamycin, enhances Na(+)-K(+)-CL- cotransport activity in cultured medullary thick ascending limb cells. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083527
|
Langrehr JM et al. |
Indefinite small bowel allograft survival after limited immunosuppressive therapy is not due to specific hyporesponsiveness. |
1991 |
Transplant. Proc. |
pmid:1721425
|
Zou XM et al. |
Immunosuppressive effect of FK506 on orthotopic liver and small bowel xenotransplantation (xenoOLTx and SBTx). |
1996 |
Transplant. Proc. |
pmid:8658729
|
Honbo T et al. |
The oral dosage form of FK-506. |
1987 |
Transplant. Proc. |
pmid:2445068
|
Holt DW et al. |
Therapeutic monitoring of sirolimus: its contribution to optimal prescription. |
2003 |
Transplant. Proc. |
pmid:12742490
|
Sundberg AK et al. |
Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant recipients: a focus on opinions and outcomes. |
2002 |
Transplant. Proc. |
pmid:12176640
|
Cailhier JF et al. |
CMV in kidney transplants in the tacrolimus-mycophenolate era. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267255
|
Renner FC et al. |
The risk of polyomavirus-associated graft nephropathy is increased by a combined suppression of CD8 and CD4 cell-dependent immune effects. |
2013 |
Transplant. Proc. |
pmid:23726630
|
Laftavi MR et al. |
The role of antibiotic prophylaxis in the new era of immunosuppression. |
2011 |
Transplant. Proc. |
pmid:21440753
|
Roat MI et al. |
Treatment of Cogan's syndrome with FK 506: a case report. |
1991 |
Transplant. Proc. |
pmid:1721457
|
Ochiai T et al. |
Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat. |
1987 |
Transplant. Proc. |
pmid:2484094
|
McCauley J et al. |
Long-term lipid metabolism in combined kidney-pancreas transplant recipients under tacrolimus immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267475
|
Konno O et al. |
Early Outcomes of Living-Donor Kidney Transplantation With Immunosuppression Therapy Induction With Tacrolimus Extended-Release: A Comparison With Cyclosporine. |
2018 |
Transplant. Proc. |
pmid:30316378
|
Pinho-Apezzato ML et al. |
Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience. |
2010 |
Transplant. Proc. |
pmid:20620519
|
Undre NA et al. |
Pharmacokinetics of tacrolimus (FK506) in primary orthotopic heart transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636451
|
Suarez Benjumea A et al. |
Hepatitis C Virus in Kidney Transplant Recipients: A Problem on the Path to Eradication. |
2016 |
Transplant. Proc. |
pmid:27932111
|
Rathi M et al. |
Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study. |
2015 |
Transplant. Proc. |
pmid:26036543
|
Takaya S et al. |
Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. |
1991 |
Transplant. Proc. |
pmid:1703691
|